Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/04/041842
CTRI/2022/04/041842
Recruiting
未知

Efficacy of low frequency repetitive transcranial magnetic stimulation (rTMS) therapy among children with focal onset drug refractory epilepsy ââ?¬â?? A single arm interventional study - TMS THERAPY

DGAFMS0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: G969- Disorder of central nervous system, unspecified

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: G969- Disorder of central nervous system, unspecified
Sponsor
DGAFMS
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DGAFMS

Eligibility Criteria

Inclusion Criteria

  • •Children and adolescents of either sex aged 4 \-18 years diagnosed with drug refractory epilepsy as per with ILAE 2017\. Drug refractory epilepsy will be defined as ââ?°Â¥ 1 seizure / week OR 4 seizures/month despite on ââ?°Â¥ 2 appropriately chosen and optimally prescribed antiepileptic drugs.
  • •1\.Duration of epilepsy for atleast 1 year
  • •2\.Seizures of single semiology
  • •3\.Majority (75%) of Interictal epileptiform discharges (SWI) arising over a single epileptogenic focus on sleep EEG
  • •4\.Parents/ guardians willing to follow the treatment protocol of daily sessions for 10 days in 2 week with Sunday off and hospital follow up at 12 weeks of total study period

Exclusion Criteria

  • •1\.Hemispheric epilepsy syndromes such as Rasmeussenââ?¬•s encephalitis, Hemiconvulsion\-hemiplegia epilepsy syndrome or Hemimegalancephaly.
  • •2\.Diagnosed epileptic encephalopathy other than focal ESES (Electrical status epilepticus in sleep)
  • •3\.Diagnosed progressive neurological disorder
  • •4\. Previous epilepsy surgery or vagal nerve stimulation insertion.
  • •5\.Patient waitlisted for epilepsy surgery within 6 months
  • •6\.Presence of Metallic implants anywhere in the body.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical effectiveness of repetitve transcranial magnetic stimulation (rTMS) as an adjunctive therapy in depression - a catchment area-based randomised controlled trialMajor depressive disorderMental and Behavioural DisordersDepression
ISRCTN70121208South London and Maudsley NHS Trust (UK)54
Completed
Phase 3
Effects of high frequency repetitive transcranial magnetic stimulation and sertraline on depressive symptoms in patients after ischemic strokePost stroke depressionRepetitive transcranial magnetic stimulationAntidepressant
TCTR20180112001Faculty of Medicine Chulalongkorn University15
Recruiting
Not Applicable
The safety and efficacy of repetitive transcranial magnetic stimulation on eating behaviors and body weight in obesity: A randomized, single-center, single blinded, parallel design, placebo-controlled study
KCT0002548The Catholic University of Korea, St. Vincent's Hospital40
Not yet recruiting
Not Applicable
Effect of transcranial magnetic stimulation therapy on pain i rheumatoid arthritis patients
CTRI/2024/03/064740All India Institute of Medical Sciences
Recruiting
Not Applicable
Effects of rTMS in rehabilitation after stroke
IRCT20100720004422N8Tabriz University of Medical Sciences36